EUVIMEDEUVIMED entdecken
Open Access · CC BY 2.0

Heparan sulfate promotes autoactivation of procathepsin K by destabilizing the propeptide–catalytic domain interaction

Huanmeng Hao, Xiaoxiao Zhang, Jian Liu, Ding Xu iD

Biochemical Journal · 2026

DOI: 10.1042/bcj20260109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical Journal, 2026. Verfasst von Huanmeng Hao und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, School of Medicine, Emory University, Atlanta, GA, U.S.A. Hauptthemen laut MEDLINE: Cathepsin K, Heparan Sulfate, Enzyme Precursors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 2.0). Gefördert von: NIAMS NIH HHS, NIDCR NIH HHS, HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Procathepsin K (pro-CtsK) is the zymogen of cathepsin K (CtsK), a collagenase that is essential for bone resorption. Pro-CtsK is known to bind heparan sulfate (HS), but the biological significance of the interaction remains unclear. Here, we report that HS accelerates the autoprocessing of pro-CtsK in a manner dependent on both sulfation pattern and oligosaccharide length. We discovered a previously unknown electrostatic interaction between the propeptide and the catalytic domain, which stabilizes the conformation of the propeptide and prevents it from intermolecular proteolytic activation. HS accelerates autoprocessing of pro-CtsK by disrupting this critical electrostatic interaction. Mechanistically, HS competes with two glutamic acids in the propeptide for binding to three basic residues on the catalytic domain, thereby substantially altering the conformation of the propeptide and making it more labile for autoprocessing. We further discovered that HS is highly enriched in secretory lysosomes of osteoclasts and might be directly involved in autoactivation of CtsK.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cathepsin KHeparan SulfateEnzyme PrecursorsCatalytic DomainOsteoclastsAnimalsHumansEnzyme ActivationLysosomes

Stichwörter der Autor:innen

Proteasecathepsinglycosaminoglyanlysosomeosteoclasts

Substanzen

Cathepsin KHeparan SulfateEnzyme Precursors

Autor:innen und Institutionen

  • Department of Orthopaedics, School of Medicine, Emory University, Atlanta, GA, U.S.A.
  • Department of Oral Biology, School of Dental Medicine, University at Buffalo, the State University of New York, Buffalo, NY, U.S.A.
  • Division of Chemical Biology and Medicinal Chemistry, Eshelman School of Pharmacy, University of North Carolina, Chapel Hill, NC, U.S.A.
  • Department of Biochemistry, School of Medicine, Emory University, Atlanta, GA, U.S.A.

ORCID-Profile: Ding Xu

Förderung

  • NIAMS NIH HHS
  • NIDCR NIH HHS
  • HHS | NIH | National Institute of Dental and Craniofacial Research (NIDR)
  • HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Zitieren

APA

Hao, H., Zhang, X., Liu, J., & Xu, D. (2026). Heparan sulfate promotes autoactivation of procathepsin K by destabilizing the propeptide–catalytic domain interaction. Biochemical Journal. https://doi.org/10.1042/bcj20260109

Vancouver

Hao H, Zhang X, Liu J, Xu D. Heparan sulfate promotes autoactivation of procathepsin K by destabilizing the propeptide–catalytic domain interaction. Biochemical Journal. 2026. doi:10.1042/bcj20260109

BibTeX
@article{Hao2026,
  author = {Hao, Huanmeng and Zhang, Xiaoxiao and Liu, Jian and Xu, Ding},
  title = {Heparan sulfate promotes autoactivation of procathepsin K by destabilizing the propeptide–catalytic domain interaction},
  journal = {Biochemical Journal},
  year = {2026},
  doi = {10.1042/bcj20260109}
}
Kostenlos starten →